AI

  • Rebuilding trust in the NHS: AI as the catalyst for human-first care

    By Alfred Olivares, Global Managing Partner, Healthcare & MedTech at HTEC The NHS, once the envy of the world, is now facing the expectations of a generation raised on instant access and personalised services. Research from the Independent Healthcare Provider Network shows that half of millennials plan to use private healthcare in the next year, [...]

  • Arbiter closes US$52m seed round

    Healthcare platform Arbiter has raised US$52m in seed funding from family offices, valuing the New York company at about US$400m. The start-up, which aims to reduce fragmentation in healthcare systems, secured backing from specialist healthcare investors including TriEdge, MFO Ventures and WindRose Health Investors rather than traditional venture capital firms. The investors bring operational experience [...]

  • New report reveals 93 per cent of healthcare professionals believe AI will improve patient care

    A new report from System C, ‘AI with Purpose: Insights from 300 Voices Shaping the Future of Health and Social Care,’ reveals a strong appetite for artificial intelligence across the NHS and wider healthcare sector – with the majority of respondents agreeing that AI can help streamline tasks and improve care delivery. The findings, published [...]

  • Stock markets rise as Nvidia CEO quells AI ‘bubble’ fears

    Global markets rose after Nvidia posted third-quarter earnings that exceeded Wall Street estimates, easing concerns about AI sector valuations. The chipmaker reported US$1.30 in diluted earnings per share on US$57.01bn in total revenues, beating investor expectations of US$1.26 on US$54.9bn. Sales increased 62 per cent year on year. Nvidia, the world's most valuable [...]

  • App uses AI to tackle £72 billion NHS multimorbidity challenge

    Holly Health, in collaboration with Loughborough University and Modality Partnership, has completed an Innovate UK–funded 18-month project focused on advancing digital self-management for people living with or at risk of multimorbidity. By combining behavioural science with machine learning technology within the Holly Health app, the Biomedical Catalyst project introduced a just-in-time adaptive intervention (JITAI) system. [...]

  • Round up: Powerful AI-powered tool for neuroscience revealed

    HT World explores the latest research developments in the world of health technology World's most comprehensive AI-powered tool for neuroscience unveiled The new Brain Knowledge Platform (BKP) has been unveiled by Allen Institute researchers and engineers. This first-of-its-kind database and research tool has just launched with data from over 34 million brain cells. [...]

  • Can AI chatbots break the silence? Rethinking men’s mental health support

    By Dr Serufusa Sekidde                      Years ago, I lost a patient to suicide. He was bright, outwardly strong, and yet, like so many men, he suffered in silence. I feel like I missed the warning signs and that’s why that tragedy still weighs heavily on me. [...]

  • One in four UK patients turning to AI for health information

    Almost a quarter of UK patients are turning to AI for guidance, with Gen Z patients most likely to ask ChatGPT before their GP, new research has revealed. The survey of 2,000 UK patients found that one in four patients (24 per cent) already use AI for health guidance, and one in three (30 per [...]

  • Massive virtual brain allows researchers to study disease like never before

    Scientists have built a virtual mouse cortex using a supercomputer, simulating 10 million neurons to study diseases like Alzheimer's and epilepsy. The simulation models both the structure and function of a whole mouse cortex, containing nearly 10 million neurons, 26 billion synapses and 86 interconnected brain regions. Synapses are tiny connections between brain cells that [...]

  • TandemAI closes US$22M Series A extension round

    TandemAI has secured US$22m in a Series A extension to advance its drug discovery platform. The round, from new and existing investors, takes total funding past US$80m since October 2021. The platform combines artificial intelligence with physics-based computation and wet-lab work to find potential drug candidates. The platform has produced more than ten [...]